Logo image of AXS.AS

ACCSYS TECHNOLOGIES PLC (AXS.AS) Stock Fundamental Analysis

Europe - AMS:AXS - GB00BQQFX454 - Common Stock

0.762 EUR
0 (0%)
Last: 10/1/2025, 12:27:52 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AXS. AXS was compared to 11 industry peers in the Paper & Forest Products industry. The financial health of AXS is average, but there are quite some concerns on its profitability. AXS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AXS has reported negative net income.
AXS had a positive operating cash flow in the past year.
In multiple years AXS reported negative net income over the last 5 years.
In the past 5 years AXS always reported a positive cash flow from operatings.
AXS.AS Yearly Net Income VS EBIT VS OCF VS FCFAXS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

AXS has a worse Return On Assets (-12.63%) than 72.73% of its industry peers.
Looking at the Return On Equity, with a value of -23.48%, AXS is doing worse than 72.73% of the companies in the same industry.
The Return On Invested Capital of AXS (3.81%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -12.63%
ROE -23.48%
ROIC 3.81%
ROA(3y)-12.79%
ROA(5y)-7.46%
ROE(3y)-23.46%
ROE(5y)-13.64%
ROIC(3y)N/A
ROIC(5y)N/A
AXS.AS Yearly ROA, ROE, ROICAXS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

The Operating Margin of AXS (5.60%) is better than 72.73% of its industry peers.
AXS's Operating Margin has improved in the last couple of years.
AXS has a worse Gross Margin (30.32%) than 63.64% of its industry peers.
AXS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.6%
PM (TTM) N/A
GM 30.32%
OM growth 3Y14.91%
OM growth 5Y30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y0.04%
AXS.AS Yearly Profit, Operating, Gross MarginsAXS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXS is destroying value.
AXS has more shares outstanding than it did 1 year ago.
AXS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AXS has a worse debt to assets ratio.
AXS.AS Yearly Shares OutstandingAXS.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
AXS.AS Yearly Total Debt VS Total AssetsAXS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

AXS has an Altman-Z score of 1.07. This is a bad value and indicates that AXS is not financially healthy and even has some risk of bankruptcy.
AXS's Altman-Z score of 1.07 is on the low side compared to the rest of the industry. AXS is outperformed by 63.64% of its industry peers.
AXS has a debt to FCF ratio of 6.79. This is a slightly negative value and a sign of low solvency as AXS would need 6.79 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 6.79, AXS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that AXS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, AXS is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 6.79
Altman-Z 1.07
ROIC/WACC0.5
WACC7.54%
AXS.AS Yearly LT Debt VS Equity VS FCFAXS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.11 indicates that AXS has no problem at all paying its short term obligations.
AXS has a Current ratio of 2.11. This is amongst the best in the industry. AXS outperforms 81.82% of its industry peers.
A Quick Ratio of 1.09 indicates that AXS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.09, AXS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.09
AXS.AS Yearly Current Assets VS Current LiabilitesAXS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

4

3. Growth

3.1 Past

AXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.07%.
Looking at the last year, AXS shows a small growth in Revenue. The Revenue has grown by 0.34% in the last year.
The Revenue has been growing by 8.49% on average over the past years. This is quite good.
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%204.35%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y4.18%
Revenue growth 5Y8.49%
Sales Q2Q%-0.85%

3.2 Future

AXS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.15% yearly.
Based on estimates for the next years, AXS will show a small growth in Revenue. The Revenue will grow by 6.14% on average per year.
EPS Next Y109.12%
EPS Next 2Y52.29%
EPS Next 3Y35.15%
EPS Next 5YN/A
Revenue Next Year5.01%
Revenue Next 2Y8.04%
Revenue Next 3Y11.48%
Revenue Next 5Y6.14%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AXS.AS Yearly Revenue VS EstimatesAXS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
AXS.AS Yearly EPS VS EstimatesAXS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 0 0.05 -0.05 -0.1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AXS. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 73.98, AXS can be considered very expensive at the moment.
AXS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, AXS is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 73.98
AXS.AS Price Earnings VS Forward Price EarningsAXS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXS is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as AXS.
Industry RankSector Rank
P/FCF 20.94
EV/EBITDA 13.49
AXS.AS Per share dataAXS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AXS's earnings are expected to grow with 35.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.29%
EPS Next 3Y35.15%

0

5. Dividend

5.1 Amount

AXS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACCSYS TECHNOLOGIES PLC

AMS:AXS (10/1/2025, 12:27:52 PM)

0.762

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)06-24 2025-06-24/amc
Earnings (Next)11-24 2025-11-24
Inst Owners39.92%
Inst Owner ChangeN/A
Ins Owners0.75%
Ins Owner ChangeN/A
Market Cap184.93M
Analysts84.44
Price Target0.01 (-98.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.97%
PT rev (3m)-5.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)29.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 73.98
P/S 1.35
P/FCF 20.94
P/OCF 17.25
P/B 1.9
P/tB 2.03
EV/EBITDA 13.49
EPS(TTM)-0.1
EYN/A
EPS(NY)0.01
Fwd EY1.35%
FCF(TTM)0.04
FCFY4.78%
OCF(TTM)0.04
OCFY5.8%
SpS0.56
BVpS0.4
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.63%
ROE -23.48%
ROCE 5.08%
ROIC 3.81%
ROICexc 4.3%
ROICexgc 4.51%
OM 5.6%
PM (TTM) N/A
GM 30.32%
FCFM 6.46%
ROA(3y)-12.79%
ROA(5y)-7.46%
ROE(3y)-23.46%
ROE(5y)-13.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y33.54%
ROICexcg growth 5Y42.93%
ROICexc growth 3Y34.09%
ROICexc growth 5Y43.81%
OM growth 3Y14.91%
OM growth 5Y30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y0.04%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 6.79
Debt/EBITDA 3.17
Cap/Depr 20.49%
Cap/Sales 1.38%
Interest Coverage 3.87
Cash Conversion 63.55%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.09
Altman-Z 1.07
F-Score5
WACC7.54%
ROIC/WACC0.5
Cap/Depr(3y)140.37%
Cap/Depr(5y)274.36%
Cap/Sales(3y)7.53%
Cap/Sales(5y)14.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%204.35%
EPS Next Y109.12%
EPS Next 2Y52.29%
EPS Next 3Y35.15%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y4.18%
Revenue growth 5Y8.49%
Sales Q2Q%-0.85%
Revenue Next Year5.01%
Revenue Next 2Y8.04%
Revenue Next 3Y11.48%
Revenue Next 5Y6.14%
EBIT growth 1Y832.66%
EBIT growth 3Y19.71%
EBIT growth 5Y41.18%
EBIT Next Year248.7%
EBIT Next 3Y68.25%
EBIT Next 5YN/A
FCF growth 1Y137.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.95%
OCF growth 3Y67.8%
OCF growth 5Y35.14%